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Abstract: In the area of biomedicine, research for designing electrochemical sensors has evolved over
the past decade, since it is crucial to selectively quantify biomarkers or pathogens in clinical samples for
the efficacious diagnosis and/or treatment of various diseases. To fulfil the demand of rapid, specific,
economic, and easy detection of such biomolecules in ultralow amounts, numerous nanomaterials have
been explored to effectively enhance the sensitivity, selectivity, and reproducibility of immunosensors.
Graphene quantum dots (GQDs) have garnered tremendous attention in immunosensor development,
owing to their special attributes such as large surface area, excellent biocompatibility, quantum
confinement, edge effects, and abundant sites for chemical modification. Besides these distinct
features, GQDs acquire peroxidase (POD)-mimicking electro-catalytic activity, and hence, they can
replace horseradish peroxidase (HRP)-based systems to conduct facile, quick, and inexpensive
label-free immunoassays. The chief motive of this review article is to summarize and focus on the
recent advances in GQD-based electrochemical immunosensors for the early and rapid detection of
cancer, cardiovascular disorders, and pathogenic diseases. Moreover, the underlying principles of
electrochemical immunosensing techniques are also highlighted. These GQD immunosensors are
ubiquitous in biomedical diagnosis and conducive for miniaturization, encouraging low-cost disease
diagnostics in developing nations using point-of-care testing (POCT) and similar allusive techniques.
Keywords: graphene quantum dots (GQDs); nanomaterials; electrochemical immunosensors; cancer
diagnosis; infectious diseases; cardiovascular disorders
1. Introduction
Over the last several years, cancer and cardiovascular diseases (CVDs) have become two major
causes of death for several age groups worldwide. At the same time, several pathogenic diseases like
bacterial and viral infections, as well as diseases caused by toxins, are prevailing across the globe.
Diagnosis of such diseases by detecting them at a very early stage has led to the development of
preventive medicines rather than conventional medicines (i.e., treatment-based), which is now quite
possible by virtue of biosensors. The very first biosensor introduced was an electrochemical glucose
sensor by the pioneers Clark and Lyon in 1960s [1]. Since then, biosensors are highly demanded
and employed in biomedical applications, particularly for disease monitoring, drug discovery, and
detection of biomolecules (i.e., disease biomarkers, pollutants, toxins, and disease-causing microbes) in
biological samples such as blood, urine, saliva, sweat, food, and environmental contents [2–8].
The International Union of Pure and Applied Chemistry (IUPAC) defines a biosensor as “a device
that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues,
organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical
signals” [9]. These analytical devices convert a biological or chemical response into an electrical signal
and are usually classified on the basis of the type of bioreceptors involved in bio-recognition events,
i.e., enzyme [10], antibody [11], peptide [12], aptamer [13], DNA [14], and molecularly imprinted
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polymer (MIP)-based sensors [15,16], or according to the type of transducer employed, such as
electrochemical [17], optical [18], piezoelectric [19], and calorimetric biosensors [20]. The general
working principle behind all of the biosensors is portrayed in Figure 1. Amidst these sensors, the one
with antibody as a bio-recognition element is one of the most important and widely studied sensing
platforms. Such platforms are often termed as immunosensor, since they function on the basis of
immunoreaction (i.e., specific recognition) between antigens and antibodies [21,22]. They can meet the
needs of specific and rapid identification of the bio-recognition molecules, as well as the on-line and
real-time detection requirements of modern analytical procedures. Therefore, immunosensors can
offer a broader platform for research and development.
Figure 1. Schematic representation of a biosensor. MIP, molecularly imprinted polymer.
Nanomaterials, the quintessential materials of nanotechnology with noticeably three-dimensional
(3D) space, have sizes ranging within a nanoscale (1–100 nm) [23]. In the recent plot, the research
regarding various nanomaterials is emerging with a giant footstep, due to which they are progressively
becoming a sector of routine in terms of cosmetics, food safety, drug delivery, therapeutics,
environmental sciences, biosensors, and many others [24–26]. By means of these, unprecedented paths
for exposure of nanomaterials to living beings and the environment are expanding.
In the development of immunosensors, nanomaterials have been explored as electrode modifiers
to enhance the antibody loadings due to their good adsorption ability, biocompatibility, and structural
compatibility. Enduringly, these nanomaterials constitute discrete biological and physicochemical
properties compared to their conventional counterparts, which bestow them favorable characteristics for
the fabrication of biosensors. They exhibit surface effects, small size effects, and macroscopic quantum
tunneling effects, hence they have unique mechanical, electrical, optical, magnetic, and catalytic
properties as compared to the bulk materials [27–30]. Moreover, they have also been employed
as nanocarriers for signaling elements (detector bioreceptors, enzymes, and/or electroactive label),
as catalysts and electron transfer promoters for signal amplification [31–34], thus providing new
approaches for the development and application of bioelectrochemical sensors.
To date, plenty of nanomaterials have been investigated as signaling species, including
nanoparticles (NPs) [35–37], nanowires [38], carbon nanotubes (CNTs) [39], graphene [40–42],
magnetic beads [43,44], and quantum dots (QDs) [45,46], to further improve the sensitivity, selectivity,
and reproducibility of electrochemical immunosensors. Among these materials, QDs, like carbon
dots and graphene quantum dots (GQDs), have gained popularity for their unique characteristics
such as good biocompatibility, electro-catalytic activity, controllable size, good signal amplification,
and multiplexed detection ability. They are chemically stable, water soluble, robust, inert, and
photo-stable against blinking and photo-bleaching. Moreover, it is easy to synthesize and functionalize
these nanomaterials [46–52].
GQDs are zero-dimensional (0D) carbon nanomaterials, composed of a framework analogous to
graphene, with properties derived from both graphene and carbon dots [53]. They are extensively used
for biological, optoelectronics, and environmental applications, and their phenomenal characterization
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has directed its pertinence in electrochemistry as well [46,54,55]. They are anisotropic with lateral
dimension greater than the height, having mono- or multiple layers of graphene, and possess chemical
groups on their edge that serves abundant sites for functionalization [46]. Figure 2 depicts the chemical
structure of GQDs.
Figure 2. Structure of graphene quantum dots (GQDs).
Being fluorescent nanoscale graphene fragments, GQDs result into exciton confinement in 3–20 nm
particles and quantum-size effect [56,57]. Due to the fact that graphene is a zero band gap nanomaterial,
it is non-luminescent, renders quantum confinement in fixed sized species, and has an infinite excitation
Bohr radius [58]. However, GQDs contain a band gap because of size, edge effects, and quantum
confinement that can be easily regulated by modifying their surface chemistry and size [55,58]. Unlike
semiconductor QDs having two quantum states at a given energy level, GQDs exhibit four. These
supplementary quantum states make them efficient for quantum computing [46,59]. Moreover, GQDs
can be grafted with various other nanomaterials via pi–pi network to form hybrid nanomaterial [59].
Synthesis of GQDs with controllable size can be achieved by either top-down or bottom-up
approaches [60]. In top-down methods, two-dimensional (2D) graphene or graphene oxide (GO)
sheets, carbon fibers, CNTs, or graphite are dissected to form 0D GQDs, whereas in bottom-up
processes, they are synthesized via stepwise reactions of small molecular precursors [54,57]. GQDs
tend to form conjugates with proteins, nucleic acids, and antibodies, since they are identical to such
compounds by virtue of their small size. They can enlarge the effective surface of immunosensors
through the absorption of a considerable number of antibodies by providing large free room [48,61,62].
Besides, GQDs are capable enough to catalyze hydrogen peroxide (H2O2) by acting as nanozymes
for the label-free detection of analytes [63]. They acquire peroxidase (POD)-mimicking catalytic
properties, which lead to simultaneous oxidation and reduction of an electron–donor substrate and
H2O2, respectively. In the field of biosensors, horseradish peroxidase (HRP), a peroxidase enzyme,
is usually employed, where the labeling of a secondary receptor for target detection is a necessity, thus
resulting in tedious and more expensive assay procedures [14]. To conduct these assays quickly and
economically, GQDs can be employed to avoid HRP-labeled secondary antibodies [47,63,64].
Emerging research on GQDs in designing electrochemical immunosensors has been conducted
incredibly in the last five years, owing to their attractive features [63,65–67]. Moreover, scientists have
zeroed in on the development of such immunosensors for biomedical applications via the usage of (a)
biomarkers or pathogens responsible for the respective disease type, (b) highly specific and sensitive
immunosensors, and (c) various bioassays. According to the National Institutes of Health, a biological
marker (biomarker) is defined as, “A characteristic that is objectively measured and evaluated as
an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a
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therapeutic intervention” [68]. The use of biomarkers and pathogens in detecting and treating certain
diseases in their very early phase is being assumed to develop continuously in coming years.
In this review, we discuss the working principle, new accomplishments, and progress of
electrochemical immunosensors based on GQDs for several important biomedical applications,
especially, for diagnosing and monitoring several types of cancers, cardiovascular diseases, and infections,
before the direst of their symptoms take over. The research regarding the pivotal role of GQDs in
designing and enhancing the performance of electrochemical antibody biosensors is a primary emphasis
of this review, which summarizes the former studies of GQD-based electrochemical immunosensors
and further expansion of their practical applications.
2. Electrochemical Sensors
Electrochemical sensors are supremely attractive when compared to optical and thermal sensors,
owing to their unique detectability, experimental simplicity, and cost effectiveness. They have a
prominent position among the currently accessible sensors that have reached the commercial stage and
have been well-known for a wide range of important applications in the area of biomedicine [69–71].
This sensor type can function as a miniaturized device for point-of-care testing (POCT) [72,73].
Usually, electrochemical sensors comprise two basic elements, (a) a molecular recognition
system which is the most significant part of a sensor, and (b) a physicochemical transducer system
which is a component that converts the chemical or biological response into a signal that can
be detected by modern electrical instrumentations. These two parts build a working (or sensing)
electrode. A reference electrode, and often a counter electrode, are also engaged in the electrical
measurements [74,75]. The IUPAC defined an electrochemical immunosensor as “an integrated
device based on an antigen/antibody reaction, which can convert certain chemical substances or their
concentration signals into a corresponding electric signal through the sensor element, and realize
a specific quantitative or semi-quantitative analysis” [76]. As shown in Figure 3, these sensors are
based on immunoassays, where the antibodies (by means of capture and detection agents) specifically
bind to their respective antigens (analyte or target molecule) such as disease biomarkers, pathogens,
toxins, or interact with components of the host’s immune system, i.e., the antibodies have high affinity
towards their respective antigens [77,78].
Figure 3. Analytical principle of electrochemical immunosensors.
In relation to immunoreactions, electrochemical antibody sensors can be based on various bioassay
formats, for instance, direct, indirect, competitive, or sandwich modes. All of these immunoassays
share a common basic principle (Figure 4) and generally involve the following steps [78]:
(a) Capture of the analyte of interest (usually target antigen);
(b) Occlusion of the non-reacted surface; and
(c) Recognition of the analyte.
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Figure 4. Various modes of bioassays employed in the development of electrochemical
immunosensors [72].
Of all of the bioassay formats, the direct immunoassay is the most straightforward form of analyte
detection. It covers the integration of a target molecule on the sensor surface, followed by washing as
well as blocking steps, thenceforth allowing an effective immobilization of a specific labeled antibody
for the recognition of a desired analyte. However, in an indirect immunoassay, a labeled secondary
antibody is subjected to a specific primary antibody [72,79]. In the case of a sandwich assay, antigens are
“sandwiched” between the capture and detection antibodies through two different binding sites [11,80].
The competitive assays are further classified into two: Direct and indirect forms. The former
approach works either by competing free antigens with labeled antigens to interact with the immobilized
antibodies, or by competing immobilized free antigens with each other to react with labeled primary
antibodies, while the later approach involves the binding of a labeled secondary antibody to a primary
antibody for determining the target analyte. The indirect competitive assay is usually preferred when
the labeled primary antibodies are not available, which overcomes the issues of incorrect antibody
immobilization and loss of affinity [71,72,78]. All of the immunoassays displayed in Figure 4 are based
on the use of a label. They compute the signals generated by the label, leading to versatile and sensitive
detection. Nevertheless, the immunosensors can also be label-free, which have the ability to encounter
the physical changes during the immuno-complex formation [72,81,82].
Antibody biosensors can offer benefits of a wide linear response range, low detection limits,
reproducibility, and good stability. Transduction of a biochemical reaction into an electrical signal
can be accomplished either by amperometry, conductometry, impedimetry, potentiometry, or by
voltammetry. This section entails the fundamentals of the often used electrochemical techniques for
sensing biomarkers and/or pathogens. We elaborate a general outline of how the detection of different
analytes can be achieved through such methods. Additionally, we describe their merits and limitations
to guide the interested readers to choose the most suitable technique for a specific analysis.
2.1. Amperometric Sensors
Amperometric sensors measure a current flow generated by an electrochemical reaction at a
constant voltage. The intrinsic principle behind these sensors is the specific molecular recognition
of antigens by antibodies to establish a stable complex. Amperometric immunosensing can be (a)
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direct (non-labeled): Detection of the physical changes caused during immune complex formation;
or (b) indirect (labeled): Using signal-generating labels. Since most of the protein analytes fail to act as
redox couples, electrochemically-tagged labels are fused into the immunocomplex that results into
the indirect measurement of the analyte. Besides, indirect amperometric immunosensing is usually
preferred over the direct mode of measurement, owing to its high sensitivity and versatility [83]. These
sensors involve the use of a potential applied between a working and a reference electrode to oxidize
or reduce an electroactive species by measuring the resultant current [69]. Thus, current generated
by the electrochemical reaction is directly proportional to the concentration of the electroactive
species in the sample [84]. Figure 5A shows the ideal behavior of sensor signals generated by
amperometric measurements.
Figure 5. (A) Amperometric curves for the different concentrations of target analyte. (B) Nyquist
plot: Change in the impedance upon electrode functionalization and analyte addition. (C) Cyclic
voltammogram of a GQD-coated electrode, where its electrochemical response varies upon the specific
binding of antibody to analyte. (D) Potential time profile of square wave voltammetry (SWV), where E1:
Initial potential; E2: Potential after pulse; f: Pulse frequency; t: Pulse duration. (E) Representation of
the analyte detection by means of GQD-coated electrodes, where the variation in current is proportional
to the antibody occupancy.
2.2. Conductometric Sensors
Conductometric sensors measure the conductivity at a series of frequencies [69]. They are
dependent upon conductance and a bio-recognition event. When a bio-recognition element interacts
with an antigen, the current flow or conductivity of the solution is varied due to the change in
concentration of ionic species [85]. Contrarily, there is a change in conductivity of the supporting
electrolyte, when antibodies labeled with enzyme are fused to antigens in the sample solution,
the enzymatic activity is inhibited by the antigen–antibody complex by blocking the surface of the
electrode [17]. The resultant signal can be measured by an ohmmeter or multimeter. The conductometric
detection obeys ohm’s law, i.e., S = χ× (A/L); where S is conductivity, χ is specific conductivity, A is area,
and L is distance between the immersed electrodes. Advantages of sensors based on the conductometric
principle include: (a) Propriety of thin-film electrodes for miniaturization, (b) reference electrode is
not required, (c) transducers are not light-sensitive, (d) lower driving voltage to cut down the power
consumption [86].
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2.3. Impedimetric Sensors
A large number of research works have been emphasized on the perception of capacitive or
impedimetric-based immunosensors. Impedance spectroscopy has been broadly employed for surface
characterization, label-free detection, and determination of binding kinetics between biomolecules such
as receptors, DNAs, proteins, antibodies, antigens, etc. [17,87]. The impedance is based on faradic or
non-faradic measurements, i.e., in the presence or absence of a redox couple, respectively. The faradic
immunosensors detect bio-recognition events taking place at the modified electrode by computing the
change in the faradaic current, i.e., interfacial electron transfer resistance due to the steric hindrance
caused by the biomolecular interaction and/or by the electrostatic repulsion between the free charges
of the target molecules and the electroactive species in the supporting electrolyte [87,88].
Electron impedance spectroscopy (EIS) interprets the response of an electrochemical cell to a small
amplitude sinusoidal voltage signal as a function of frequency. The resulting current sine wave alters
in time (phase shift) with respect to the voltage wave, and this current–voltage ratio (V(t)/I(t)) gives the
impedance (Z) [89,90]. To retrieve the information about the bio-reaction occurring at the interface,
simulated circuit (i.e., Randles equivalent circuit) can be used to express charge transfer resistance (Rct),
electrolyte resistance (Rel), Warburg impedance (W), mass transfer resistance (Rmt), and double-layer
capacitance (Cdl) [91].
Bode and Nyquist plots are commonly used to interpret electrochemical impedance data. In the
former plot, the total impedance (|Z|) is plotted against the frequency, while in the latter plot (Figure 5B),
the imaginary part of impedance (−Z”) is plotted against the real part of impedance (Z′) [92]. In an
electrochemical cell, diffusion phenomena, electrode kinetics, redox reactions, as well as molecular
interactions on the surface of an electrode are akin to the resistors, capacitors, and inductors that
impede the electrons’ flow in an alternating current (AC) circuit. Features that make these sensors
attractive involve the ability to be miniaturized, remote control of implanted sensors, cost-effective
electrode mass production, and economical instrumentation [89].
2.4. Potentiometric Sensors
The potential difference is measured by potentiometric immunosensors due to the immunocomplex
formation between antibody and antigen [17]. These sensors are less sensitive, since the change in
potential is small during the immunoaffinity reaction. Also, they are less accurate, less stable, and exhibit
non-specific binding. Considering these limitations, potentiometric methods are less preferred over
other electrochemical sensing techniques [93]. On the contrary, the ease of operation, use in automation,
and miniaturization of solid-state sensors are the major advantages of such immunosensors [94].
2.5. Voltammetric Sensors
The general features of all voltammetric techniques are that they involve the application of a
potential (E) to an electrode and control the resulting current (i) flowing through the electrochemical
system. With time, the applied potential causes a change in the concentration of an electroactive
species on the electrode surface via oxidation or reduction. The analytical merits of such techniques
include excellent sensitivity with a wide concentration range for both organic and inorganic species,
being able to work in a wide range of temperatures, rapid analysis, simultaneous detection of different
analytes, and determination of kinetic parameters. Voltammetric sensing techniques include cyclic
voltammetry, linear sweep/scan voltammetry, differential pulse voltammetry, square wave voltammetry,
polarography, and stripping voltammetry. A two- or three-electrode electrochemical sensor containing
a potentiostat can be employed to measure the current [95–99].
Cyclic voltammetry (CV) is based on varying the applied potential at a working electrode in both
forward and reverse directions while controlling the current (Figure 5C). For instance, the initial scan
could be in a negative direction to the switching potential, which would then be reversed and run in a
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positive direction. Depending on the analysis, one full cycle, a partial cycle, or a series of cycles can be
performed [97].
Normal pulse voltammetry (NPV) amplifies a series of potential pulses in an increasing order.
The current is measured near the end of each pulse. Usually, the duration of each pulse is 1–100 ms and
the interval between each pulses is 0.1–5 s [95,96]. Differential pulse voltammetry (DPV) is relatable to
NPV, where the potential is also scanned with a series of pulses. Nevertheless, it differs from NPV
because each potential pulse is fixed, of small amplitude (10–100 mV). Current is measured twice for
each pulse, i.e., just before the application of the pulse and at the end of the pulse [95,96].
The excitation signal in square wave voltammetry (SWV) comprises a symmetrical square wave
pulse, where the forward pulse of the square wave coincides with the staircase step (Figure 5D).
The peak height is directly proportional to the concentration of the electroactive species. SWV exhibits
excellent sensitivity, ignores background currents, and enhances the signal to noise ratio [98,99].
Figure 5E depicts the SWV response with respect to the different steps tangled from the electrode
modification to the analyte determination.
The main advantage of pulse techniques like DPV and NPV lies in the different decay rates of
the faradaic and capacitive currents. The capacitive current is negligible as compared to the faradaic
current, since it decays many folds faster than the faradaic current during each pulse. Such an increased
ratio of the faradaic current to the capacitive current allows for a lower detection limit, which makes
such methods suitable for the electrochemical detection of analytes [100]. Nevertheless, pulse strategies
and SWV, are probably the most sensitive among all of the electrochemical characterization techniques,
and hence most extensively employed for analytical purposes [101,102].
3. GQD-Based Electrochemical Immunosensors for Cancer Diagnosis
Cancer emerges from the transformation of normal cells into tumor cells in multiple stages,
i.e., carcinogenesis/tumorigenesis or oncogenesis, that usually arises from a pre-cancerous lesion to
a malignant tumor [103,104]. It has now become the leading cause of death in all age groups due
to several factors, including exposure to certain radiations [105] and carcinogenic chemicals [106],
infection by bio-carcinogens (e.g., certain bacteria, viruses, or parasites) [107], aging, genetic factors,
geographic location, and improper and/or unhealthy diet [108,109].
Cancer rates and fatality are promptly sprouting across the globe. An estimation of around 18.1
million cancer cases and 9.6 million human deaths worldwide was reported in 2018 [110]. Considering
the dramatic rise in cancer rates, recent advances in engineering electrochemical immunosensors have
axiomatically improved the sensitivity required to detect very low concentrations of cancer biomarkers
present in human biological fluids. Early stage biosensing of these analytes is the inaugural step
towards hindering metastasis, adopting efficient therapy, and reducing mortality rate. Moreover, some
immunosensors possessing multiplexing capability have also been reported for simultaneous detection
of multiple cancer biomarkers [111,112]. Herein, we reviewed the recently developed GQD-based
electrochemical immunosensors for cancer diagnosis. Important features of these sensors, such as the
choice of electrode, assay type, electrochemical sensing technique, investigation range, and limit of
detection, are also summarized in Table 1.
Carcinoembryonic antigen (CEA) is one of the major tumor markers associated with the diagnosis
and controlling of malignant tumors, such as pancreatic, colorectal, lung, liver, breast, and gastric
cancers [113–118]. It is an oncofetal glycoprotein with a molecular weight of 180–200 kDa [119], which
is generally expressed by mucosal cells and overexpressed by various malignancies [120,121]. Elevated
level of CEA in human blood (>5 ng mL−1) is an indication of cancer cell formation [116]. Very
recently, Ganganboina et al. developed a label-free impedimetric immunosensor based on nitrogen-
and thiol-doped GQDs (N,S–GQDs) and gold-embedded polyaniline (Au–PANI) nanowires for the
ultrasensitive and extremely selective detection of CEA [122]. The excellent electro-conductivity of
N,S–GQDs/Au–PANI nanowires enhance the electron transfer. Figure 6 shows the immobilization
of N,S–GQDs onto the Au–PANI surface via Au–thiol linkage after depositing Au–PANI onto the Pt
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electrode. N,S–GQDs act as the bifunctional probe to link anti-CEA and to amplify the electrochemical
activity. The detection principle of CEA was based on the change in impedance of N,S–GQDs/Au–PANI
after the introduction of CEA, suppressing the electron transfer after the conjugation of antibody–antigen
on the N,S–GQDs/Au–PANI surface. This label-free immunosensor displays a wide linear range from
0.5 to 1000 ng mL−1, with a limit of detection (LOD) of 0.01 ng mL−1.
Figure 6. Stepwise construction of a label-free carcinoembryonic antigen (CEA) electrochemical
impedimetric immunosensor.
Another label-free immunosensor for the quantification of CEA based on PtPd/N–GQDs/Au
functionalized glassy carbon electrode (GCE) was fabricated by Yang et al. in 2017 [67]. Preparation
of PtPd/N–GQDs/Au via a self-assembly approach due to covalent binding is depicted in Figure 7.
The synergistic effect of nanocomposites in PtPd/N–GQDs/Au provide the electro-catalytic activity
towards hydrogen peroxide (H2O2) reduction, good biocompatibility, excellent conductivity, and large
surface area; thus, PtPd/N–GQDs/Au was employed as transducer to effectively immobilize capture
antibodies and to serve as a signal amplification platform. The specificity of this sensor was investigated
against non-specific biomolecules like hepatitis B surface antigen (HBS), prostate specific antigen (PSA),
human immunoglobulin (IgG), and BSA, whereas the variation in amperometric response of these
samples with interference and CEA was found less than 5% of that without interferences, suggesting
that the designed immunosensor is highly selective. This label-free amperometric immunosensor
could attain high sensitivity and long-term stability for the detection of CEA, with a linear calibration
plot ranging from 5 fg mL−1 to 50 ng mL−1, and the LOD was found as 2 fg mL−1.
Figure 7. (A) Synthesis of PtPd/N–GQDs/Au nanocomposites. (B) Set-up of the label-free electrochemical
amperometric immunosensor for CEA detection.
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Table 1. Various GQD-loaded immunosensing platforms reported (2016 onwards) for cancer diagnosis.
Electrode Nanomaterials Biomarker Assay Type Technique(s) Sample(s) Linear Range LOD Reference
Pt-electrode N,S–GQDs/Au–PANI CEA Direct EIS Human serum 0.5–1000 ng mL−1 0.01 ng mL−1 [122]
GCE PtPd/N–GQDs/Au CEA Direct Amperometry Human serum 5 fg mL−1–50 ng mL−1 2 fg mL−1 [67]
GCE P5FIn/erGO/GQDs/Au CEA Sandwich ECL Human serum 0.1–10 ng mL−1 3.78 fg mL−1 [123]
SPCE MWCNTs/GQDs IL-13Rα2 Sandwich Amperometry
Raw cellular
lysates from
human CRC
2.7–100 ng mL−1 0.8 ng mL−1 [124]
SPdCE MWCNTs/GQDs IL-13Rα2,CDH-17 Sandwich Amperometry
Raw cellular
lysates from
human CRC and
breast cancer
4.92–100 ng mL−1
(IL-13sRα2)
0.11–10 ng mL−1
(CDH-17)
1.44 ng mL−1
(IL-13sRα2)
0.03 ng mL−1
(CDH-17)
[112]
SPCE N,S–GQDs/AuNPs HCG Direct CV, SWV, EIS Human serum 0.1–125 pg mL−1 12.5 fg mL−1 [61]
Au-electrode P-Cys/GQDs/AuNPs p53 Direct SWV, DPV Human plasma 0.0488–12.5 pM 23.4 fM [125]
GCE CysA/AuNPs/GQDs CA 15-3 Direct SWV, CV
Human plasma;
cellular lysates
from human
breast cancer
0.16–125 U mL−1 0.11 U mL−1 [126]
GCE Au/Ag–rGO/GQDs PSA Direct EIS, ECL Human serum 1 pg–10 ng mL−1 0.29 pg mL−1 [127]
GCE GQD/GS PSA Sandwich SWV Human serum 0.005–10 ng mL−1 3 pg mL−1 [128]
GCE GN–Ag–Au/GQDs CA 199 Sandwich ECL Human serum 0.002–70 U mL−1 0.96 mU mL−1 [129]
Abbreviations: Ag: Silver; AuNPs: Gold nanoparticles; CA 15-3: Carcinoma antigen 15-3; CA 199: Carbohydrate antigen 199; CEA: Carcinoembryogenic antigen; CDH-17: Cadherin-17;
CRC: Colorectal cancer; CV: Cyclic voltammetry; CysA: Cysteamine; DPV: Differential pulse voltammetry; ECL: Electrochemiluminescence; EIS: Electron impedance spectroscopy; erGO:
Electrochemically reduced graphene oxide; GCE: Glassy carbon electrode; GN: Graphene; GS: Graphene sheets; GQDs: Graphene quantum dots; HCG: Human chorionic gonadotropin;
IL-13Rα2: Interleukin-13 receptor α2; MWCNTs: Multi-walled carbon nanotubes; N,S–GQDs: Nitrogen- and thiol-doped graphene quantum dots; p53: Tumor protein-53; P5FIn:
Poly(5-formylindole); PANI: Polyaniline; P-Cys: Poly L-cysteine; Pd: Palladium; PSA: Prostate-specific antigen; Pt: Platinum; r-GO: Reduced graphene oxide; SPCE: Screen-printed carbon
electrode; SPdCE: Screen-printed dual carbon electrode; SWV: Square wave voltammetry.
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An antibody sensor exploring the role of GQDs for quantitative determination of CEA was
constructed by Nie and coworkers [123]. Here, the sensing strategy involved reinforcement of GQDs
with poly(5-formylindole)/electrochemically-reduced graphene oxide nanocomposite (P5FIn/erGO)
and Au nanoparticles (AuNPs). As an effective matrix, P5FIn/erGO nanocomposite facilitates the ion
transport during the redox reactions and offers a large free-room for the bio-immobilization of primary
antibody, whereas both GQDs and AuNPs as labels improve electron transfer efficacy during their
conjugation with secondary antibody. By virtue of such multiple signal amplification properties of
P5FIn/erGO and GQDs/AuNP, the as-prepared sandwich immunosensor led to quantify the target
biomarker, allowing a dynamic linear range from 0.1 pg mL−1 to 10 ng mL−1 in human serum, with a
detection limit of 3.78 fg mL−1.
Several studies have demonstrated that overexpression of interleukin-13 receptorα2 (IL13Rα2) can
be found in a variety of human cancer cells such as colorectal, glioma, squamous cell carcinoma of head
and neck, and AIDS-associated Kaposi’s sarcoma [130]. Very recently, Serafín and coworkers introduced
an integrated amperometric electrochemical immunosensor for the determination of IL-13Rα2, which
involves the immobilization of a biotinylated specific capture antibody onto streptavidin-modified
screen-printed carbon electrodes (SPCEs) through grafting with p-amino benzoic acid (p-ABA)
and further surface activation via EDC/NHS chemistry [124]. A hybrid nanomaterial comprising
multi-walled carbon nanotubes (MWCNTs) and GQDs was opted as a nanocarrier of the detector
antibody and HRP molecules. The use of this hybrid material considerably improves the assay due to
the peroxidase-like activity of GQDs. Amperometric detection of IL-13Rα2 by H2O2/hydroquinone
(HQ) system revealed a wide dynamic concentration range (2.7–100 ng mL−1), with an LOD value of
0.8 ng mL−1, and can be applied for quick and selective determination of IL-13Rα2 in raw cell lysates
from human colorectal cancer cells.
In another study, the same group established a dual electrochemical immunoassay for the
simultaneous detection of IL-13Rα2, as well as CDH-17, present in lysates from breast and colorectal cancer
cells, respectively, with different metastatic potential [112]. Herein, MWCNT/GQD-functionalized
screen-printed dual carbon electrode (SPdCE) was assembled to form a sandwich assay. The preparatory
steps for integrating the electrode surface, as well as the detection strategy, were carried out similarly as
reported in their aforementioned work. This dual amperometric sensor could selectively determine both
biomarkers, i.e., IL-13sRα2 and CDH-17, with respective LOD values of 1.4 ng mL−1 and 0.03 ng mL−1.
In 2019, Roushani and Valipour constructed an economic, facile, and label-free electrochemical
immunosensor for the accurate and selective quantification of human chorionic gonadotropin (HCG)
in human serum [61]. The N,S–GQDs, as well as AuNPs, were casted one after the other on SPCE,
as illustrated in Figure 8. This modification not only increased the antibody loading, but also improved
the electrochemical signal for protein analysis, thereby effectively enhancing the sensitivity of the sensor.
In order to electrochemically characterize the surface modifications, the electrode was submitted to CV
and EIS techniques, whereas DPV was used for the quantification of HCG by scanning the potential of
−0.1 to 0.5 V. To study the reproducibility of the proposed sensor, the inter-assay, as well as intra-assay,
precisions were performed for the same HCG levels with five measurements. As a result, the relative
standard deviations (RSDs) were found to be 2.9% and 3.5%, respectively. This suggests that the
N,S–GQD/AuNP-modified SPCE has a wide potential window with good reproducibility.
Materials 2020, 13, 96 12 of 30
Figure 8. Experimental steps to fabricate an SPCE for monitoring HCG levels.
In 2018, an electrochemical immunosensor based on ternary signal amplification strategy to modify
gold electrode was designed by Hasanzadeh et al. for the ultrasensitive recognition of p53, a tumor
suppressor protein [125]. In this research, biotinylated p53 antibody was immobilized onto a green
and biocompatible nanocomposite film consisting of poly L-cysteine (P-Cys) as polymetric conductive
matrix and GQDs/AuNPs as synergetic amplification elements. A blend of such nanocomposites
increases the effective surface area to immobilize a large number of anti-p53 antibodies. Under
optimized conditions, the sensor provided a linear response between 0.0488 and 12.5 pM and an LOD
of 23.4 fM.
The same research team has also reported a label-free immunoassay for the accurate quantification
of a breast cancer-specific protein, CA 15-3 [126]. In this approach, modification of GCE surface
was initiated by electrochemically assembling the AuNPs onto thiolated graphene quantum dots
using cysteamine (CysA), as well as 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and
N-hydroxysuccinimide (NHS). The subsequent CysA/AuNPs/GQDs hybrid interface provided stability
and large loading of CA 15-3 molecules for their effective immobilization, thereby increasing the
number of binding events occurring between the antigen and antibodies (Figure 9). The sensor
fabrication, as well as the immunoreaction, were investigated by CV and SWV techniques, where
the drop in the SWV peak current of [Fe(CN)6]3−/4− was attributed to the response of the CA 15-3
antibody binding to the sensor. The prepared device can be applied to CA 15-3 malignant cell line
lysates (human breast adenocarcinoma cell line-MCF-7) for breast cancer diagnosis.
Wu et al. proposed a label-free electrochemiluminescent immunosensor for prostate-specific
antigen (PSA) using GQDs as GCE modifiers [127]. Incorporation of aminated as well as acarboxyl
GQDs on gold/silver nanoparticle-reduced graphene oxide (Au/Ag–rGO) further increased the surface
area of GCE and electron transferability, resulting in increased electrochemiluminescence (ECL).
However, anti-PSA immobilization on the surface of modified electrode reduced the ECL intensity
through the adsorption of Au/Ag toward proteins. The resulting immunosensor responded a calibration
curve of PSA concentration in the range of 1 pg mL−1–10 ng mL−1, with an achievement of 0.29 pg mL−1
as the detection limit.
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Figure 9. Schematic presentation of an electrochemical immunosensor for the detection of CA 15-3.
Considering PSA as a model analyte, a sandwich-type electrochemical sensor was also engineered
for its quantification in human serum [128]. During the sensor preparation, GQD-functionalized
graphene sheets (GS) were employed as labels to conjugate primary as well as secondary anti-PSA
antibodies. Moreover, the authors reported electrochemical detection of PSA by SWV technique with a
wide range of linear response (0.005–10 ng mL−1) and high sensitivity (LOD: 3 pg mL−1). This can be
ascribed to the increased loadings of antibody on the electrode surface and good conductivity provided
by such nanomaterials.
Yang and coworkers assembled an ECL immunosensor by modifying a GCE surface for the
selective determination of carbohydrate antigen 199 (CA 199), a potent tumor marker in diagnosing
pancreatic cancer [129]. As indicated in Figure 10, the fabrication process involved the integration of a
sensor surface using gold–silver nanocomposite-functionalized graphene (GN–Ag–Au) and porous
PtPd nanochain-implanted GQDs (PtPd–GQDs). Owing to the favorable physical and chemical
properties exhibited by these hybrid nanomaterials, GN–Ag–Au provided a large surface area to
capture a huge number of primary antibodies and boosted the electronic transmission rate, while
PtPd–GQDs delivered a large loading of secondary antibodies. This sandwich assay led to an improved
sensitivity, achieving a broad detection range (0.002–70 U mL−1) and LOD of 0.96 mU mL−1 CA 199
concentration in human serum. Further, the authors reported that this biosensor was able to retain
almost 96% of its initial activity, even after 7 weeks, and therefore has long-term stability, which
could be attributed to the excellent biocompatibility of GQDs, as well as the strong bonding between
secondary antibodies and PtPd–GQDs.
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Figure 10. Casting procedure of a sandwich-based immunosensor for CA 199 detection [129].
4. GQD-Based Electrochemical Immunosensors for Monitoring Cardiovascular Diseases
CVDs are the disorders of heart and blood vessels, which include coronary heart disease,
cerebrovascular disease, rheumatic heart disease, and other conditions [78]. CVDs account for almost
one-third of all deaths worldwide, which results in significant morbidity [131], and four-fifths of
CVD deaths are due to heart attacks and strokes. Individuals at risk of CVD may have symptoms
such as raised blood pressure, glucose, and lipids, as well as overweight and obesity, which can be
readily measured in primary care facilities. Identifying those at highest risk of CVDs and ensuring
they receive appropriate treatment can prevent premature deaths [132]. It is therefore noteworthy to
diagnose patients with high risk of acute myocardial infarction at an early stage, which can reduce
cost by screening the hospital admissions process and focusing resources on those that are specifically
at high risk [78]. Thus, prognostic biomarkers are required to be measured with minimally invasive
methodologies to improve the management of CVDs. These biomarkers, which are detected in the
patient’s blood, can provide clinical evidence help in disease prognosis based on the change in level of
certain cardiac biomarkers with respect to the severity of a particular CVD [133–135].
Electrochemical immunosensors hold divergent marvellous features, rendering them highly
appropriate for the quantification of CVD biomarkers at very low concentrations in biological
fluids. The exclusive benefits of these sensors in terms of high sensitivity and stability conveyed by
nanostructuring the sensor surface, combined with high affinity and selectivity of bioreceptors, have
resulted in the development of innovative electrochemical immunosensing strategies, which have been
introduced as impressive substitutes to conventional techniques for clinical diagnosis and monitoring
of CVD. To the best of our knowledge, only four GQD-based electrochemical immunosensors have
been reported to date for detecting CVD biomarkers. A brief overview of these sensors is shown in
Table 2. It is worth noting that all of these GQD sensors were reported after 2016, implying that the use
of GQDs for the development of electrochemical immunosensors is evolving.
Table 2. GQD-linked immunosensors designed over the last five years to detect cardiac biomarkers.
Electrode Nanomaterials Biomarker Technique(s) Linear Range LOD Reference
SPCE
GQDs
implanted
with 2-ABA
AXL DPV 1.7–1000 pg mL−1 0.5 pg mL−1 [136]
SPGE PAMAM/GQDs cTnI CV, DPV 10−6–10 ng mL−1 20 fg mL−1 [137]
SPCE GQDs cMyo CV, DPV, EIS 0.01–100 ng mL−1 0.01 ng mL−1 [66]
SPCE GQDs CRP EIS 0.5–70 nM 176 pM [138]
Note: All of the four abovementioned immunosenors follow direct mode of bioaassay. Abbreviations: 2-ABA:
2-aminobenzyl amine; AXL: Tyrosine kinase receptor; cMyo: Cardiac myoglobin; CRP: C-reactive protein; cTnI:
Cardiac troponin I; CV: Cyclic voltammetry; DPV: Differential pulse voltammetry; EIS: Electron impedance
spectroscopy; GQDs: Graphene quantum dots; PAMAM: Polyamidoamine; SPCE: Screen-printed carbon electrode;
SPGE: Screen-printed gold electrode.
Materials 2020, 13, 96 15 of 30
AXL is a tyrosine kinase receptor. The proteolytically refined extracellular portion of this protein
(sAXL) is contemplated as a relevant biomarker in the pathophysiology of heart failure (HF). The level of
sAXL in serum is elevated in HF patients, with a threshold value of 71 ng mL−1 [139,140]. Mollarasouli et
al. recently engineered a label-free disposable electrochemical immunosensor for the detection of AXL,
where functionalization of SPCE/GQDs involved the electropolymerization with 2-aminobenzyl amine
(2-ABA) by cyclic voltammetry (20 cycles at 200 mVs−1 from 0.0 to −1.0 V vs. Ag pseudo-reference
electrode) [136]. To ensure the adhesion of GQDs to the SPCE surface, the modified electrode was
placed in an oven for 1 h at 120 ◦C. The specific anti-AXL antibody was subsequently immobilized
through the stabilization of Schiff bases between amino-modified GQDs and aldehyde groups, induced
on the antibody by periodate-mediated oxidation of their carbohydrate residues. After incubating the
anti-AXL/GQDs/SPCE electrode for 1.5 h at room temperature, the immunorecognition of the target
analyte was tracked by measuring the reduction in DPV response of the redox probe [Fe(CN)6]3−/4−,
as represented in Figure 11. This modification led to an LOD of 0.5 pg mL−1.
Figure 11. Display of the anti-AXL antibody immobilization on the GQDs/SPCE electrode through the
oxidized sugar chains and electrochemical detection of AXL [136].
Tuteja and co-workers fabricated a label-free impedimetric electrochemical immunosensor for the
sensitive detection of cardiac myoglobin (cMyo) [66], an early indicator of acute myocardial infarction
(AMI) [141]. Hydrothermally-synthesized GQDs were laminated on screen-printed electrodes (SPEs) as
an immobilized template. Subsequent incubation of this electrode with the anti-myoglobin antibodies
allowed the realization of a selective sensor system for myoglobin. The charge transfer resistance
(Rct) values were generated as a function of varying antigen concentration and depicted a linear
increase (from 0.20 to 0.31 kΩ) in the range of 0.01–100 ng mL−1 cMyo. This bioelectrode could also be
regenerated for a minimum of five cycles. The estimated limit of detection, 0.01 ng mL−1, was almost
400 times improved when compared to the ELISA tests (estimated 4 ng mL−1).
In 2017, Bhatnagar et al. designed an ultrasensitive electrochemical immunosensor for the rapid
sensing of cardiac troponin I (cTnI), a biomarker responsible for heart attack (myocardial infarction) in
humans [137]. In this study, screen-printed gold electrode (SPGE) was embedded with a linker molecule
4-aminothiophenol (4-ATP) for amine termination of the electrode surface, and these amino groups
were further coupled with carboxyl groups of GQD via EDC/NHS reaction. In order to enhance the
sensitivity of the device, polyamidoamine (PAMAM) dendrimer was consecutively decorated on GQD
through carbodiimide coupling. These hybrid nanomaterials act as gold electrode modifier to offer an
ultra-high surface area for antibody immobilization. The activated cTnI monoclonal antibody was
then mounted on PAMAM to form nanoprobe for sensing cTnI antigen (Figure 12). The recognition of
cTnI was monitored by decrease in the [Fe(CN)6]3− oxidation peak using cyclic voltammetry (CV) and
differential pulse voltammetry (DPV), achieving a lower LOD of 20 fg mL−1 and a broad concentration
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range of cTnI (10−6–10 ng mL−1). Moreover, the as-prepared sensor was claimed to detect cTnI in
human blood serum within 10 min.
Figure 12. Various steps tangled in designing the label-free immunosensor for cTnI involving
GQDs/PAMAM-modified SPGEs and immobilization of anti-cTnI. (CE: Counter electrode, WE: Working
electrode, RE: Reference electrode). Adapted from [137].
Atrial fibrillation (AF) during open heart surgery can be interrupted by prophylactic beta-blockers
(BB) [142]. In spite of carrying out plenty of studies during the past few years, adequate protection
against AF in patients with post-coronary artery bypass graft surgery (CABG) has not been successfully
achieved by BB. Assuming the relation between high C-reactive protein (CRP) levels and AF, it is
debatable if high plasma CRP levels are only responsible for the occurrence of AF, or if raised CRP
levels cause the disorder [143,144]. Bing et al. reported the use of GQDs as GCE modifiers to develop
a proficient and effective electrochemical immunosensor for CRP detection in blood serum [138].
The stepwise construction of a receptive surface was characterized via EIS measurements. The Rct
values were target-specific, showing a linear relationship with logarithmic CRP concentration 0.5–70 nM
and a low limit of detection of 176 pM. It is reported that this immunosensor could detect CRP in a
single step and is able to detect clinical AF after CABG.
5. GQD-Based Electrochemical Immunosensors for the Detection of Infectious Diseases
Infections due to a plethora of microbes are a threat to the modern healthcare system. In total, there
is a large number of about 1400 known species of disease-causing human pathogens, which mainly
constitute water and foodborne micro-organisms like bacteria, virus, fungi, etc. [145]. Among these,
bacterial and viral infections remain the predominant cause of mortality and morbidity, particularly
in developing nations [146]. Lack of sanitation or poor access to treatment are the two major factors
associated with such contagion. Besides, the prevalent use of pesticides is immensely and equally
responsible for posing inimical health hazards and/or for polluting the environment with toxins.
The severity of the contagious diseases and widespread use of detrimental chemical residues
have triggered breakthrough inventions in introducing versatile and portable biosensors for the rapid,
specific, and sensitive detection of the target analytes in clinical as well as environmental sectors.
However, numerous conventional culturing techniques are already in use for the identification and
quantification of pathogens, but their limitations reside in less sensitivity, high cost instrumentation,
requirement of highly skilled technicians and long assay times, and incapability to perform on-site
monitoring. It is therefore a great challenge and quite significant to gain an on-field detection of
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microbes, as well as pesticide residues, in biological samples and to implement the preventive measures
for their inactivation. This has now become considerably feasible thanks to the development of
biosensors. In a broader range, electrochemical immunosensors have been extensively investigated
by the use of multiplexing electrodes and nanomaterials like GQDs, where such sensor systems have
been witnessed to conduct utterly inexpensive, reliable, ultrasensitive, and accurate quantification
of antigens involved in environmental monitoring, as well as healthcare. Table 3 lists some major
characteristics of GQD immunosensors for the detection of various bacteria, viruses, and toxins.
In 2019, Altintas et al. developed a novel, rapid, ultrasensitive, and highly specific label-free
immunosensor approach for the efficacious diagnosis of Yersinia enterecolitica. The sensor preparation
was initiated by enrichment of gold electrode surface with GQDs, owing to their enzyme-mimicking
property to catalyze H2O2 [63]. In this approach, the bio-immobilization of antibodies was followed by
inactivating unreacted carboxyl groups on the sensor surface with bovine serum albumin (BSA) and
ethanolamine (EA), as depicted in Figure 13. The amperometric quantification of Y. enterocolitica at
−0.2 V in the presence of H2O2 relied on the extent of inhibited electron transfer of the GQDs, which was
blocked by the immunocomplex formation. As a result, signal reduction was observed with the increase
in bacterial concentration. The resulted sensor exhibited a wide concentration range in complex media
like milk and human serum, as mentioned in Table 3, with a very low detection limit of 5 cfu mL−1 and
30 cfu mL−1 in milk and human serum, respectively. It is worth mentioning that the matrix effect did
not influence the sensor performance sufficiently, as the investigation range and the limit of detection
in buffer were quite similar. The sensor revealed an LOD of 1 cfu mL−1 with higher electronic signals
in buffer than those of complex matrices. Moreover, the specificity of the developed immunosensor
was very high in the co-existence of several interfering bacteria (i.e., Salmonella enteritidis, Bacillus
anthracis, Escherichia coli and Yersinia pestis), which further demonstrated the tempting characteristic of
GQD-based immunoassays. This GQD sensor seems to be an attractive analytical tool that can pave
the way for the identification of any pathogenic bacterium in clinical and food samples.
Tufa’s team constructed a sandwich immunosensor for the determination of Mycobacterium
tuberculosis antigen (culture filtrate protein, CFP-10) containing a GQD-laminated Fe3O4@Ag core–shell
nanostructure (Fe3O4@Ag/GQDs) and anti-CFP-10/AuNPs as GCE enhancer and labels for signal
amplification, respectively [147]. This nanotriplex-based sensing platform rendered a noticeable
synergetic electrochemical performance by the different functions of these nanomaterials, where Fe3O4
increased the surface-to-volume ratio; Ag improved electrical conductivity; and GQDs delivered large
loading of the anti-CFP-10 antibody onto the electrode. Quantification of AuNPs by exposing the
antigen–antibody complex to a potential of 1.3 V for 40 s and scanning by DPV revealed a wide linear
range from 0.005 to 500 mg mL−1 with an LOD of 0.33 ng mL−1.
Figure 13. Steps involved in the development of a GQD-based immunosensor for Y. enterocolitica
detection [63].
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Table 3. Electrochemical antibody sensors involving the use of GQDs for pathogen detection.
Electrode Nanomaterials Pathogen AssayMode Technique(s) Sample(s) Linear Range LOD Reference
Gold GQDs Y. enterocolitica(bacteria) Direct Amperometry
Milk and human
serum
1–6.23 × 108 cfu mL−1
(milk);
1–6.23 × 108 cfu mL−1
(serum)
5 cfu mL−1 (milk);
30 cfu mL−1 (serum) [63]
GCE Fe3O4@AG/GQDs CFP-10 (bacteria) Sandwich DPV Human urine 0.005–500 µg mL−1 00.33 ng mL−1 [147]
GCE PDA/N–GQDs E. coli (bacteria) Sandwich ECL; CV; EIS Water 10–107 cfu mL−1 8 cfu mL−1 [148]
Platinum GQDs S. typhimurium(bacteria) Direct EIS Buffer 1 pM–100 nM 1 pM [149]
GCE AgNPs/thiol–GQDs HCV (virus) Direct DPV Human serum 0.05 pg–60 ng mL−1 3 fg mL−1 [150]
GCE N,S–GQDs/AuNPs/PANI HEV (virus) Direct CV; EIS
Buffer, human serum,
and feces of
HEV-infected monkey
1–105 fg mL−1 (feces of
HEV-infected monkey);
102–107 RNA copies mL−1
(human serum)
0.8 fg mL−1 (feces of
HEV-infected
monkey); 96.7 RNA
copies mL−1
(human serum)
[151]
GCE AuPd/N–GQDs@PS HBsAg (virus) Direct Amperometry Human serum 10 fg mL−1–50 ng mL−1 3.3 fg mL−1 [82]
Carbon GQDs/AuNBs FAdVs (virus) Sandwich CV Chicken blood 10–50 pfu mL−1 8.75 pfu mL−1 [152]
GCE Fe3O4/GQDs/Cu-apoferritin ALVs-J (virus) Sandwich DPV Human serum 102.08–104.5 TCID50 mL
−1 115 TCID50 mL−1 [153]
SPCE GQDs/2-ABA Parathion (toxin) Direct EIS Food, water, and soil 0.01–106 ng L−1 46 pg L−1 [154]
Glass GQDs/ITO AFB1 (toxin) Direct CV; EIS Contaminated maize 0.1–2.0 ng mL−1 0.03 ng mL−1 [155]
Abbreviations: 2-ABA: 2-aminobenzyl amine; AFB1: Aflatoxin B1; AgNPs: Silver nanoparticles; ALVs-J: Avian leukosis virus subgroup J; AuNBs: Gold nano-bundles; CFP-10: Culture
filtrate protein-10; cfu: Colony forming units; cu: Copper; CV: Cyclic voltammetry; DPV: Differential pulse voltammetry; E. coli: Escherichia coli; EIS: Electron impedance spectroscopy;
FAdVs: Fowl adenovirus; Fe3O4: Ferric ferrous oxide; GCE: Glassy carbon electrode; GQDs: Graphene quantum dots; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; HEV:
Hepatitis E virus; ITO: Indium tin oxide; N,S–GQDs: Nitrogen- and thiol-doped graphene quantum dots; PANI: Polyaniline; PDA: Polydopamine; PS: Polymer nanosphere; pfu: Plague
forming units; RNA: Ribonucleic acid; SPCE: Screen-printed carbon electrode; S. typhimurium: Salmonella typhimurium; TCID50: Median tissue culture infectious dose; Y. enterocolitica:
Yersinia enterecolitica.
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Depending on the ECL characteristics of nitrogen-doped graphene quantum dots (N–GQDs) and
high selectivity of polydopamine (PDA) surface imprinted polymer (SIP), an articulately developed
biosensor for the common food pathogen Escherichia coli O157:H7 was engineered by Chen at al. [148].
For the sensor preparation, dopamine and the target bacteria underwent direct electropolymerization
on the electrode. CV (−0.5 to 0.5 V, 30 cycles) was performed with a scan rate 0.02 V s−1 to form PDA
SIP. The established PDA SIP was subsequently immersed in acetic acid/SDS solution for 18 h for the
removal of bacteria template to recognize E. coli. Accordingly, specific polyclonal antibody (pAb) was
labeled with N–GQDs. The electrochemical properties of the transformed electrode were studied by
collecting the EIS and CV stepwise. This sandwich assay could reliably detect concentrations of E. coli
O157:H7 from 10 to 107 cfu mL−1, with a detection limit of 8 cfu mL−1 in water samples.
Figure 14 embodies an impedimetric electrochemical biosensor consisting of a polydimethylsiloxane
(PDMS) chamber integrated with a biofunctionalized nanoporous alumina membrane, where the
sensing principle is based on the change in electrical impedance across the membrane, before and
after the bacteria capture. The impedance increases due to the blockage of nanoporous skeleton
by bacteria, and it decreases upon the addition of antibiotics because of bacterial cell deformation.
In 2017, this capture/sensing mechanism was utilized and advanced by Ye et al. to rapidly determine
the target bacteria, and furthermore to infer bacterial response to antibiotics [149]. In the study,
Salmonella typhimurium was selected as a model pathogenic bacteria. The authors reported the use of
amino-modified GQDs for altering the membrane to increase the surface-to-volume ratio. Ensuing,
the GQD-rich alumina membrane was conjugated with the anti-Salmonella antibody by glutaraldehyde
as a linker. Such an intriguing concept led to a detection limit of 1 pM, and exhibited a specificity for
the S. typhimurium with a minimum cross-reactivity of about 5% to non-target bacteria. The proposed
sensor can detect the target bacteria within 30 min, and hence, it has conceivable clinical application
for the diagnosis of several other bacterial infections.
Figure 14. Impedimetric detection of S. typhimurium and its response to antibiotics: (a) Impedance
increases; (b) impedance decreases. Adapted from [149].
In 2017, Valipour and Roushani investigated the use of silver nanoparticles (AgNPs)/thiolated
graphene quantum dots (GQD–SH) as GCE-modifying nanocomposites, and riboflavin as redox
probe for the label-free quantification of hepatitis C virus core antigen (HCV) [150]. AgNPs were
immobilized on –SH groups of GQDs via bonding formation of Ag–S, and, consequently, the anti-HCV
molecules were loaded on the surface by chemisorption between AgNPs and –NH2 groups of antibody.
The specific recognition between antibodies and antigens was analyzed by computing the decrease
in the oxidation signal reduction of riboflavin using DPV. The proposed immunosensing platform
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demonstrated a wide linear range (0.05 pg mL−1 to 60 ng mL−1), with a limit of detection of 3 fg mL−1,
and was applied for the analysis of spiked human serum.
Very recently, Chowdhury et al. introduced a pulse-induced impedimetric immunosensor
for hepatitis E virus (HEV) detection [151]. The working electrode (GCE) was assembled with
N,S–GQDs and Au–PANI nanowires via an interfacial polymerization and self-assembly approach.
The N,S–GQDs/Au–PANI nanocomposite was conjugated covalently with antibody and an external
electrical pulse was introduced during the HEV accumulation step to enhance the sensitivity towards
virus owing to the surface expansion of the virus particle, as well as the anti-HEV-conjugated polyaniline
chain length. The as-prepared biosensor demonstrated its potentiality to detect discrete HEV genotypes
collected from human serum and from fecal specimen samples of HEV-infected monkey with a
broad concentration, as listed in Table 3. Besides, it was also reported that this sensor could exhibit
similar sensitivity to that determined by real-time quantitative reverse transcription polymerase chain
(RT-qPCR).
In 2018, another label-free GCE-based immunosensor was designed using a signal amplification
system for the detection of hepatitis B surface antigen (HBsAg) [82]. In this work, N–GQDs supported
surfactant-free AuPdCu ternary nanoparticles (AuPdCu/N–GQDs) delivered good electroconductivity
and excellent catalytic activity for the reduction of H2O2. In addition to these nanomaterials,
the electroactive polymer nanosphere (PS) integrated with polyethylenimine (PEI) was employed as an
electronic mediator to load AuPdCu/N–GQDs and as a carrier to capture anti-HBs (Figure 15).
Impedance measurements characterized the construction process of GCE, whilst amperometry
determined the linear relationship between the current signal and HBsAg concentration (10 fg mL−1–
50 ng mL−1) by scanning the potential at −0.4 V and achieved high sensitivity (LOD: 3 fg mL−1).
Figure 15. Schematic representation of a label-free impedimetric electrochemical immunosensor for
the recognition of HBV antigen and the preparation procedure of: (A) Polymer nanosphere (PS)
functionalized with polyethylenimine (PEI); (B) AuPdCu/N–GQDs@PS. Adapted from [82].
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Ahmed et al. designed an immunosensing strategy based on GQDs and template-free in situ
gold nanobundles (AuNBs) for the identification of fowl adenoviruses (FAdVs) [152]. The approach
involved a modified layer-by-layer (LbL) technique to integrate AuNB film on carbon electrodes using
L(+) ascorbic acid, gold chroloauric acid, and poly-l-lysine (PLL). The nanohybrid structure of AuNBs
and GQDs were conjugated with specific anti-FAdVs antibodies prior to the quantification of antigen.
Upon addition of the FAdV pathogen, a local electric signal enhancement revealed the detection of very
low concentrations of target virus (up to 10 pfu mL−1) with 8.75 pfu mL−1 being the LOD. The proposed
immunoassay yielded higher sensitivity (>100-fold) than the conventional ELISA.
Wang et al. reported an eminently sensitive and selective detection of avian leukosis virus
subgroup J (ALVs-J) using Fe3O4-compounded GQDs and apoferritin-encapsulated Cu (Cu–apoferritin)
nanoparticles for significantly enhancing the signal amplification [153]. In the proposed immunoassay,
GQDs were employed for the immobilization of both primary as well as secondary ALVs-J antibodies,
and at the same time, Cu–apoferritin nanoparticles were preferred as electroactive probes to be
immobilized onto Fe3O4@GQDs hybrid. Before electrochemical detection of the target virus,
the thoroughly established sandwich-type assembly was immersed in an HCl solution (pH = 2)
for 20 min to liberate Cu from apoferritin cavity that led to the quantification of ALVs-J virus, ranging
from 102.08 to 104.50 TCID50 mL−1, with a detection limit of 115 TCID50 mL−1.
Mehta et al. reported a functionalized-GQD-based label-free impedimetric antibody sensor for a
pesticide, parathion [154]. To prepare the sensor, GQDs were laminated on an SPCE as an electrochemical
substrate, and subsequently modified with 2-ABA to impart –NH2 functionality. The electrode was
then conjugated with the specific anti-parathion antibodies (Figure 16). This electrochemical sensor
attained a dynamic linear response for parathion within the range of 0.01–106 ng L−1, with a very low
detection limit of 46 pg L−1. According to the analysis of potential interferences, the as-developed
strategy can specifically sense parathion in environmental and food contents, even in the presence
of its metabolite, paraoxon. Moreover, the authors declared that this sensing platform can be reused
by regenerating it with 10 mM glycine–HCl solution at least for five regeneration cycles, offering an
economic detection principle for parathion.
Figure 16. Immunosensing of parathion by GQD-functionalized SPCE [154].
Another label-free electrochemical sensing platform utilizing GQDs was developed in 2017 for
the detection of a food toxin, aflatoxin B1 (AFB1) [155]. As shown in Figure 17, GQDs were chemically
synthesized by slightly modifying the Hummer’s method [156]. The sensor set-up involved the casting
of indium tin oxide (ITO)-coated glass electrode with hydrothermally synthesized GQDs through the
electrophoretic deposition method (EPD), followed by a covalent amide bonding linkage (CO–NH)
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of monoclonal AFB1-antibodies using EDC–NHS as a cross-linker. The electrical characterization
and biosensing studies were conducted by EIS and CV techniques. The large surface area, ease of
electron transfer capability, and good electro-conductivity of the GQD-based immunosensor provided
an improved detection limit (0.03 ng mL−1) and a wide detection range (0.1–2.0 ng mL−1) in aflatoxin
B1-contaminated maize samples. Further, this biosensor was claimed to retain its activity up until
7 weeks with good reproducibility and storage stability.
Figure 17. (A) Synthesis of GQDs. (B) EPD of GQDs onto indium tin oxide (ITO)-coated glass substrate
and subsequent immobilization of anti-AFB1 for AFB1 identification.
6. Summary and Future Prospects
The quantification of disease biomarkers and pathogens in biological samples offer relevant
information regarding the severity of certain diseases, even though their sensitivity and reliability are
still a huge challenge due to their ultralow amount. However, the electrochemical immunosensors
have now achieved the limit of detecting such analytes. The development of such sensors for early
disease diagnosis is of vital significance for clinical therapy, disease monitoring, treatment, and
discovery of preventive strategies. In this review, we discussed the outstanding contribution of GQDs
in establishing innovative immunosensors by virtue of some of their fascinating attributes, such as
excellent electro-catalytic activity, size and edge effects, numerous sites for functionalization, good
electron transferability, signal amplification, photo-stability, etc. Hence, GQDs, individually or when
combined with other nanomaterials, play a substantial role in functionalization of bio-electrodes,
allowing quite an inexpensive, rapid, facile, stable, and reproducible immunosensing platform for
practical applications. Additionally, such GQD-based electrochemical immunosensors are found to be
highly specific, extremely sensitive, and very selective, even in complex media like milk, urine, human
serum, etc., suggesting that their discriminative nature could be attributed to the physicochemical
characteristics of GQDs.
On the contrary, the use of highly expensive nanomaterials with GQDs, tedious sensor assembly
procedures, inadequate storage stability, and certain undesired aspects at nanoscale are some constraints
that forbid their mass production. Plus, many of the recently reported GQD immunosensors have not
been applied to the real world. Thus, approaches for manufacturing sensor batches and scaling-up to
bulk production, as well as their validation in clinical samples, are still under the developing phase.
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According to our detailed literature survey, 87% of GQD-based electrochemical immunosensors
in biomedical diagnosis have been reported since 2016, highlighting the evolving characteristic of such
sensing platforms. The use of GQDs for the fabrication of electrochemical immunosensors, along with
the involvement of new biomarkers and pathogens, is being speculated to progress continuously and
more significantly in the upcoming years. Further advances are expected to successfully achieve the
development of GQD immunosensors for routine clinical applications.
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